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ABSTRACT
A 68-year-old man was admitted because of tonic–clonic convulsion. He had been receiving 200 mg itraconazole for 10 days. He had 
hypokalaemia (2.2 mEq/l), hypercalcaemia (Ca
corr
 11.0 mg/dl) and elevated serum parathyroid hormone (PTH, 95 pg/ml). Ultrasound 
examination of the neck revealed a low echoic tumour. Cessation of itraconazole and fluid supplementation eradicated clinical symptoms 
and profound hypokalaemia, but serum potassium remained low normal (3.4 mEq/l) and the mild hypercalcaemia and elevated PTH were 
unchanged. To conclude, a small amount of itraconazole (200 mg) precipitated profound hypokalaemia and seizure in a patient with mild 
hyperparathyroidism and low normal serum potassium.
LEARNING POINTS
• The clinical presentation of hyperparathyroidism is very diverse.
•  Determination of corrected calcium is mandatory in critical care units.
•  A few minor things occurring together can have major clinical consequences.
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INTRODUCTION
A diagnosis of mild primary hyperparathyroidism (PHPT) in an asymptomatic patient is not uncommon. Indeed, we encountered a patient 
with very mild PHPT whose main problems were seizure and profound hypokalaemia.
CASE REPORT
A 68-year-old man was transferred to our emergency department due to tonic–clonic convulsion of the left upper extremity. 
He had mild diarrhoea for 2 days prior to this event. He had been operated on for a pyogenic iliopsoas abscess and had been receiving 200 
mg minocycline, 750 mg metronidazole and 200 mg itraconazole postoperatively for 10 days. Family history was not contributory. His serum 
potassium had been slightly depressed (3.1 mEq/l) before operation for the iliopsoas abscess (i.e. prior to the administration of itraconazole). 
Upon arrival, the patient no longer had seizures. There was no focal neurological deficit. He appeared poorly nourished (body mass index 
20.0 kg/m2) with signs of mild dehydration such as a dry tongue and reduced skin turgor. Vital signs were body temperature 36.6ºC, blood 
pressure 145/77 mmHg, pulse rate 56/min and respiration rate 22/min. A small (ca. 1.0 cm in diameter) elastic firm non-tender nodule was 
palpable on the right side of the anterior neck. Laboratory data are shown in Table 1. 
There was profound hypokalaemia (2.2 mEq/l), mild hypercalcaemia (calcium corrected for albumin 11.0 mg/dl), mild normocytic anaemia, 
high arterial pH (7.509) and elevated base excess (7.6 mmol/l). He was admitted for further evaluation.
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Serum ionized calcium and serum intact parathyroid hormone (PTH) were elevated, Fractional excretion of calcium (FE
Ca
) was normal and  % 
tubular reabsorption of phosphate (TRP) was lowered. Regarding indices of bone turnover, serum bone alkaline phosphatase was normal, but 
urinary N-terminal telopeptide (NTX) was elevated. Bone mineral density (BMD) was below age- and gender-based norms. The serum level 
of 1,25(OH)
2
D
3
 was suppressed despite a normal level of 25(OH)D, and PTH-related peptide was undetectable. Ultrasound examination of 
the neck revealed a low echoic tumour (2.3×4.7×2.2 mm) behind the left lobe of the thyroid gland and a cyst with inhomogeneous internal 
echogenicity (9.9×6.9×14.7 mm) behind the right lobe of the thyroid, suggesting parathyroid or thyroid cystic adenomas. CT scans of the 
brain and chest found no abnormalities. An abdominal CT scan revealed a stone in the right ureter and hydronephrosis, but no tumour in 
the pancreas or adrenal glands. Plasma renin activity and serum aldosterone concentration were slightly suppressed and urinary potassium 
excretion was not increased. No germ-line mutation could be found in the calcium sensing receptor (CaSR) gene.
Supplementation of fluid (1,000 ml on day 1) and potassium (94 mEq on day 1; 64 mEq on days 2 and 3; and 32 mEq on days 4–6) was performed 
and itraconazole discontinued. The treatment eradicated the overt hypokalaemia and normalized the arterial pH. Seizure and diarrhoea 
did not recur after these procedures. Nevertheless, serum calcium remained mildly elevated and the serum intact PTH concentration 
transiently returned to normal (62 pg/ml) on day 8. For the past 10 months, the patient has been completely asymptomatic. Low normal 
serum potassium (3.4–3.9 mEq/l) and mild hypercalcaemia (11.5–11.6 mg/dl after correction for albumin) with a modest elevation in intact 
PTH (91–101 pg/ml) were present at follow-up at 6–10 months.
Because the patient did not accept our proposal of further evaluation such as scintigraphy in preparation for possible parathyroidectomy, 
careful observational follow-up is being continued.
DISCUSSION
The clinical presentation of mild PHPT in this patient was extremely unusual. The initial symptom was transient seizure, which was most 
likely due to profound hypokalaemia. Although itraconazole had been administered, the duration of treatment was only 10 days and dosing 
was only 200 mg, so it was most unlikely that administration of itraconazole alone caused such profound hypokalaemia[1]. Of note, the patient 
was modestly hypokalaemic even before administration of itraconazole and after its cessation, suggesting that the PHPT may have been 
related to the hypokalaemia. In fact, Aldinger and Samaan reported that 16.9% of patients with hyperparathyroidism had hypokalaemia[2]. 
However, hyperparathyroidism per se was not associated with profound hypokalaemia as low as 2.2 mEq/l[2]. 
A. Chemistry B. Blood count
Total protein g/dl (6.7–8.3) 5.5 Leukocytes /μl (4,000–8,500) 3,000
Albumin g/dl (3.8–5.1) 2.4 Red cells ×104/μl (410–530) 322
Serum creatinine mg/dl (0.4–0.7) 0.97 Haematocrit % (39.0–52.0) 31.7
Total calcium corrected for albu-
min mg/dl (8.5–10.5)
11.0 Platelets ×104/μl (14.0–44.0) 16.4
Ionized calcium mmol/l (1.21–
1.36)
1.44 C. Arterial blood gas
Phosphate mg/dl (2.5–4.5) 2.9 pH (7.35–7.45) 7.509
Potassium mEq/l (3.4–4.8) 2.2 Base excess mmol/l (-2 to 2) 7.6
Sodium mEq/l (135–147) 147 HCO3
-- mmol/l (20–26) 31.3
Chloride mEq/l (98–110) 107 pO
2
 mmHg (80–100) 78.7
Magnesium mg/dl (1.8–2.6) 2.1 pCO
2
 mmHg (35–45) 40.2
FE
Ca
 (0.02–0.04) 0.025 Anion gap mEq/l (10–12) 8.7
Intact PTH pg/ml 95 D. BMD
1,25(OH)
2
D
3
 pmol/l (20–70) 15.7 Femur (>-2.5) -2.7
25(OH)D ng/ml (7–41) 9. L2–4 (>-2.5) -2.9
Bone ALP μg/l (3.8–22.6) 16.1 E. Urinary electrolytes
Corticotropin pg/ml (7.2–63.3) 35.6 Calcium mg/l 220
Cortisol μg/dl (4.0–18.3) 15.1 Phosphate mg/l 532
Aldosterone pg/ml (35.7–240) 29.2 Potassium mEq/l 19.3
PRA ng/ml/h (0.3–5.4) 0.2
PTHrp pmol/l (<1.1) U.D.
NTx nmol BCE/l (10.7–24.0) 49.8
Table 1: Laboratory data. 
BCE, bone collagen equivalent; BMD, bone mineral density; FECa, fractional excretion of calcium; NTx, N-terminal teropeptide; PRA, plasma renin activity; PTH, parathyroid 
hormone; PTHrp, PTH-related peptide; U.D., undetectable. Intact PTH was measured using a Roche Elecsys® chemiluminescence immunoassay at SRL, Tokyo. 
The reference range is indicated in the parentheses.
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Although the mechanism of hypokalaemia in PHPT is not well understood, metabolic alkalosis might be a candidate. Excess PTH has been 
shown to cause alkalosis and chronic hypercalcaemia can induce so-called contraction alkalosis.
Seizure due to hypercalcaemia occurs only if hypercalcaemia is very severe due to highly active PHPT[3]. However, PHPT was very mild 
in this patient, so it cannot have been the sole cause of seizure. Due to the mildness of the PHPT, not all laboratory data were typical for 
PHPT. Namely, lowered % TRP, reduced BMD and the presence of a urinary stone and normocytic anaemia were compatible with the 
diagnosis of PHPT. On the other hand, decreased 1.25(OH)
2
D
3
 despite normal 25(OH)D indicating non-enhanced 25-hydroxyvitamin D
3
 
1-alpha-hydroxylase, and normal bone alkaline phosphatase pointing to absence of increased bone turnover, were not indicative of PHPT. 
Moreover, the serum concentration of intact PTH fluctuated spontaneously above and below the upper limit of the reference range in this 
patient, which was also observed in 13% (108/861) of patients with sporadic PHPT[4] in a previous study. Although a rare adult case of mild 
hypercalcaemia with a mutation in CaSR has been reported[5], there was no inactivating mutation of CaSR in this patient. Multiple endocrine 
neoplasia and malignancy-associated hypercalcaemia were ruled out with appropriate tests.
CONCLUSIONS
Our patient with mild PHPT experienced profound hypokalaemia and seizure after administration of 200 mg itraconazole for 10 days. He 
was modestly hypokalaemic both before itraconazole administration and after its cessation. We believe the small dose of itraconazole and 
PHPT acted synergistically to produce profound hypokalaemia. Diarrhoea, albeit mild, might have worsened the hypokalaemia as well. So, 
an accumulation of mild triggering factors for hypokalaemia precipitated hypokalaemia severe enough to cause a seizure.
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